Business
ZYUS Announces Cease Trade Order
ZYUS Announces Cease Trade Order Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEW...
About this update from Zyus Life Sciences Corporation
[{"type":"text","content":"\n\n\nZYUS Announces Cease Trade Order\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\nCanada NewsWire\n\n\n/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/SASKATOON, SK, May 6, 2026 /CNW/ - ZYUS Life Sciences Corporation (the \"Company\") (TSXV: ZYUS), a clinical-stage life sciences company focused on the development and commercialization of novel non-opioid drug candidates for pain management, today announces that, further to the news release dated April 30, 2026, the Ontario Securities Commission (the \"OSC\"), has notified the Company that it has issued a failure-to-file cease trade order (\"FFCTO\"), under Multilateral Instrument 11-103 – Failure-to-File Cease Trade Orders in Multiple Jurisdictions against the Company (\"MI 11-103\"). The FFCTO was issued as a result of the delay in the filing of the Company's annual audited financial statements for the fiscal year ended December 31, 2025, the related management's discussion and analysis, and the CEO and CFO certificates relating to the audited annual financial statements as required by National Instrument 52-109 – Certification of Disclosure in Issuers' Annual and Interim Filings (collectively, the \"Annual Filings\") for the fiscal year ended December 31, 2025.\n\n\n\n\n\n\n\nAs stated in the Company's news release dated April 30, 2026, the Company was unable to file the Annual Filings prior to the April 30, 2026 filing deadline due to the additional time required to complete accounting and audit procedures for various complex accounting matters, including the valuation of certain of the Company's physical assets. The Company continues to work diligently with its auditor, KPMG LLP, and expects to file the Annual Filings on or before the week of May 18, 2026. The Company anticipates that the FFCTO will remain in place until such time as the Annual Filings are filed.The FFCTO prohibits any trading, whether direct or indirect, in respect of any security of the Company in which MI 11-103 applies, except in accordance with the FFCT...